Navigation Links
Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
Date:8/1/2013

New York, NY (PRWEB) August 01, 2013

Kantar Health, a leading global healthcare consulting firm, is pleased to announce that Kantar Health Americas CEO Mike Kelly has been honored as part of the 2013 PharmaVOICE “100 Most Inspiring People,” an annual recognition in the publication’s July/August edition.

Each year, PharmaVOICE recognizes 100 professionals in the healthcare industry who inspire and motivate others; who have the greatest influence on corporate leadership, research and development, technology, creativity, marketing and strategy; and who impact the life-sciences industry through their actions.

As CEO of Kantar Health Americas, Mr. Kelly leads a multidisciplinary team that spans the full range of healthcare expertise across clinical and commercial, including health outcomes, market access and oncology. His current focus is aligning the team to bring together these experts to deliver deeper client insights and comprehensive solutions to client needs.

PharmaVOICE notes that Mr. Kelly's respectful acknowledgement of the challenges and concrete vision of the future are helping motivate his team to reach a collective goal.

“I am honored to be chosen by PharmaVOICE for their top 100 list this year,” Mr. Kelly said. “I feel fortunate to work with such a talented and innovative team of people at Kantar Health, who inspire me every day.”

Kantar Health Global CEO Lynnette Cooke said, “Mike is well-respected by his colleagues and clients. He is the consummate mentor and has challenged and inspired many people throughout his career. All of us at Kantar Health are proud that he has received this recognition.”

Mr. Kelly is a past president of the Pharmaceutical Market Research Group and speaks at many industry conferences.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10988470.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kantar Health Launches CancerMPact Biomarker Analysis
2. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
3. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
4. Kantar Health to Present at PBIRG Annual General Meeting
5. AACR honors Hagop Kantarjian for outstanding clinical research
6. Kantar Health to Participate in CIO Summit of America Conference
7. Kantar Health Further Strengthens Its Advanced Methods and Client Consulting Capabilities in the UK
8. U.S. Healthcare BPO Market: 2018 Outsourcing for Payer, Provider & Pharmaceutical Analyzed and Forecast in New Research Report at ReportsnReports.com
9. Access MediQuip Helps Health Plans, Manufacturers Protect Lives Following Series of Surgical Device Recalls
10. InventHelp® Introduces the Wonder Comb - Modified Comb Promotes Scalp Health and Comfort (BFT-481)
11. Southwestern Ear, Nose & Throat Associates Offers Guidelines On Hearing Loss, Lack of Sleep Affecting Back-to-School Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... ... 2017 , ... Salucro, the cloud-based payment platform that has ... and provider groups, has announced that it will now offer Parasail’s payment plans ... San Francisco health-finance startup that has launched a series of tech-based products that ...
(Date:6/27/2017)... Bradley, Illinois (PRWEB) , ... June 27, 2017 , ... ... Ill. were featured in a video designed to encourage lawmakers to protect ... and National Center for Assisted Living (AHCA/NCAL), highlights the story of Chuck and Cathy ...
(Date:6/27/2017)... Monroe, CT (PRWEB) , ... June 27, 2017 , ... ... announce the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of ... and increased the administrative and waiting areas. The renovations are intended to improve patient ...
(Date:6/27/2017)... , ... June 27, 2017 , ... Children’s National Health ... Hospitals rankings, with its Neonatology program ranking #1 out of more than 1500 ... named to the coveted Honor Roll, a distinction given to the top performing children’s ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/2/2017)... -- NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company focused ... positive biochemical outcomes related to more frequent hemodialysis with ... be presented at the ERA-EDTA Congress being held June ... The research was conducted by the ... Europe (KIHDNEy) Cohort team with ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
Breaking Medicine Technology: